Coronary artery bypass grafting (CABG) remains a vital treatment for patients with
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …

Saphenous vein grafts (SVGs) remain the most frequently used conduits in coronary artery
bypass graft surgery (CABG). Despite advances in surgical techniques and …

Saphenous vein graft (SVG) failure is a common finding in patients following coronary artery
bypass graft (CABG) surgery. In the literature SVG failure rates have been reported from 25 …

Myocardial ischaemia resulting from obstructive coronary artery disease is a major cause of
morbidity and mortality in the developed world. Coronary artery bypass graft (CABG) surgery …

Up to 20% of saphenous vein grafts (SVGs) fail within 2 years of coronary artery bypass
grafting (CABG). The long-term effects of early SVG failure on major clinical events remain …

Improved outcome after coronary bypass surgery over the last decade has been attributed
largely to the increasing use of arterial conduits and their superior patency rates over that of …

Occlusive arterial disease is a leading cause of morbidity and mortality worldwide. Aside
from balloon angioplasty, bypass graft surgery is the most commonly performed …

Background The saphenous vein remains the most frequently used conduit for coronary
artery bypass grafting, despite reported unsatisfactory long‐term patency rates …

Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …

Saphenous vein graft (SVG) disease after coronary artery bypass grafting (CABG) occurs in
three phases: thrombosis, intimal hyperplasia, and atherosclerosis. Within the first month …